Hinge Health President Steps Down to Board as Q3 Revenue Jumps 52%
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health reported Q3 2026 revenue of $235 million, up 52% year over year, with GAAP operating income of $50.3 million, and raised full-year 2026 revenue guidance to $879 million-$881 million. The results themselves were already out; the fresh item is the leadership change: President Jim Pursley leaves the role January 1, 2027, and joins the board January 4, with Aaryn Pure taking over commercial operations as chief commercial officer. The transition looks orderly and planned, but it removes a senior operator at a company trading near its 52-week high after a strong run. Insiders, including the executive chairman and 10% holders, have been steadily selling under pre-arranged plans, so the stock carries a heavy supply overhang. Watch the Q4 report for whether the 52% growth rate holds as the new commercial leadership settles in.
At the time of this announcement, HNGE was trading at $116.91 on NYSE in the Life Sciences sector, with a market capitalization of approximately $9.3B. The 52-week trading range was $30.08 to $118.87. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.